Roman Shaikenov

Dr. Roman Shaikenov


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RSRoman Shaikenov
Roman Shaikenov
PSPolina Serbun
Polina Serbun
JZJingran Zhang
Jingran Zhang
HWHao Wu
Hao Wu
ZWzuobin wang
zuobin wang
SMSvetlana Morozkina
Svetlana Morozkina
The perforation of the tympanic membrane is a world-wide clinical problem resulting from trauma or infection and requiring effective regeneration methods. In recent years researchers have focused on natural polymers as promising materials for restoring the structure and function of the tympanic membrane. This review summarizes current advances in the use of natural polymers, such as silk fibroin, chitosan, hyaluronic acid, collagen, bacterial cellulose, alginates and others, for the treatment of tympanic membrane perforations. The key properties of these materials are discussed, including their biocompatibility, biodegradability, mechanical strength, and ability to support cell adhesion and proliferation. The review also covers the potential of natural polymers and their combinations in tympanic membrane regeneration and suggests the directions for future research.

12 June 2025 in Engineering Proceedings
Verified
Conference Paper
Open access
PDF file
RSRoman Shaikenov
Roman Shaikenov
VKVladislava Klimshina
Vladislava Klimshina
SMSvetlana Morozkina
Svetlana Morozkina
Petr P. SnetkovPetr P. Snetkov
Petr P. Snetkov
Mangiferin, a polyphenol derived from Mangifera indica, exhibits a wide range of pharmacological activities, positioning it as a promising candidate for applications in medicine. Its potential as an alternative to antibiotics is especially significant in agriculture and medicine, addressing the global demand for non-traditional antibacterial agents. However, its poor water solubility and low bioavailability limit its therapeutic use. Polymeric matrices could be one of the potential approaches to solve these problems, enhancing mangiferin’s bioavailability. Each delivery system exhibits unique properties such as controlled release, prolonged action and organ-specific targeting, in an ideal case each directed to specific diseases and administration routes. While promising in vitro and in vivo results highlight their therapeutic potential, challenges remain in the optimization of the matrix formulations for precise applications. Further research is needed to develop these systems and confirm their efficacy in clinical practice.

28 November 2024 in Engineering Proceedings
Verified
Conference Paper
Open access
PDF file
RSRoman Shaikenov
Roman Shaikenov
VKVladislava Klimshina
Vladislava Klimshina
YGYuliya Generalova
Yuliya Generalova
PSPolina Serbun
Polina Serbun
AKAnna Kosova
Anna Kosova
Petr P. SnetkovPetr P. Snetkov
Petr P. Snetkov
The rise in antibiotic-resistant bacterial infections is a major global health concern. The search for natural compounds that inhibit the growth of pathogens is becoming urgent. One such compound is mangiferin, a non-toxic polyphenolic compound derived mainly from Mangifera indica. In addition to antibacterial properties, it exhibits anticancer, antioxidant, immunomodulatory, analgesic and other activities. However, the clinical application of mangiferin is limited by poor solubility and bioavailability. This study describes mangiferin-loaded electrospun nanofibers based on high-molecular-weight hyaluronic acid. The nanofibers improve mangiferin delivery and possess favorable morphological characteristics and drug release kinetics, making them promising candidates for effective antibacterial dressings. This study found that an increase in the mangiferin content of the fibers led to an increase in the average diameter of the fibers. It was also found that nanofibers with different mangiferin content have similar release kinetics with an anomalous non-Fickian transport pattern: most of the mangiferin is released within 10–15 min.

15 September 2025 in 3 Biotech
Verified
Journal Article
Closed access
PDF file
RSRoman Shaikenov
Roman Shaikenov
Irina GarkushinaIrina Garkushina
Irina Garkushina

8 July 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
DIDmitri O. Ivanov
Dmitri O. Ivanov
RSRoman Shaikenov
Roman Shaikenov
SMSvetlana Morozkina
Svetlana Morozkina
Petr P. SnetkovPetr P. Snetkov
Petr P. Snetkov
RNRuslan Abdullaevich Nasyrov
Ruslan Abdullaevich Nasyrov
IKIgor Kvetnoy
Igor Kvetnoy
The review evaluates current clinical and epidemiological evidence regarding the use of plant-derived compounds in pediatric practice. Data from randomized controlled trials indicate symptomatic efficacy of selected agents—particularly in acute respiratory infections—alongside generally favorable safety profiles when standardized preparations are used. Emerging research also explores applications in neurodevelopmental disorders, gastrointestinal conditions, and dermatology, and as supportive therapy in pediatric oncology. However, variability in product quality, limited pediatric-specific trials, potential toxicity, and regulatory inconsistencies remain significant challenges. The integration of phytotherapy into pediatric care therefore requires rigorous study design, careful safety monitoring, and clear quality standards to ensure an evidence-based risk–benefit balance.

Verified
Journal Article
Open access
PDF file
PSPolina Serbun
Polina Serbun
RSRoman Shaikenov
Roman Shaikenov
Petr P. SnetkovPetr P. Snetkov
Petr P. Snetkov
AKAnna Kosova
Anna Kosova
MBMikhail Budanov
Mikhail Budanov
SMSvetlana Morozkina
Svetlana Morozkina
This review presents an interdisciplinary analysis of small-molecule-encapsulated smart polymer materials for tissue engineering. Key design principles, including biocompatibility, degradation, and mechanical properties, are discussed, as well as the fabrication methods (hydrogels, electrospinning, porous matrices, and 3D printing). The following strategies for the immobilization of therapeutic agents are compared: physical retention, affinity binding, secondary carriers, post-loading, and covalent conjugation. Four main release mechanisms are analyzed, as well as material characterization, and the release kinetics are discussed. Preclinical in vitro and in vivo studies, including the disease models and the mechanistic validation, are presented, as well as a critical review of the clinical trials, identifying the following main reasons for failure: the lack of the superiority over the standard therapy, the complexity of the manufacturing, and the scale-up. The role of artificial intelligence in the acceleration of property prediction and system optimization is highlighted. Limitations are outlined and it is shown that successful translation requires a minimum level of sufficient complexity and a reproducible relationship between the structure, release, and the therapeutic window.